742885
Last Update Posted: 2018-08-20
Recruiting has ended
All Genders accepted | 20 Years-64 Years |
100 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine
This trial will assess the immunogenicity and safety elicited by the adjuvanted GSK Biologicals' (pre-) pandemic influenza candidate vaccine in healthy Japanese adults.
Eligibility
Relevant conditions:
Influenza
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov